FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Amneal Recalls Contaminated Tablets

Amneal Pharmaceutical recalls three lots of sulfamethoxazole/trimethoprim tablets because they may exhibit black spots on their tablet surface due to ...

Human Drugs

Arvinas Files NDA for Breast Cancer Drug

Arvinas files an NDA for vepdegestrant for treating patients with estrogen receptor-positive human epidermal growth factor receptor 2-negative ESR1-mu...

Medical Devices

FDA: Draeger Recall is Class 1

FDA says a Draeger recall of breathing circuit components is Class 1.

Human Drugs

ICH M11 Technical Specification Guidance Out

FDA publishes the International Council on Harmonization technical representation of its M11 guideline protocol template.

latest-news-card-1
Human Drugs

House Posts FDA Budget Mirroring Trumps Proposal

The House Appropriations Committee posts FDAs budget bill for FY 2026 that mirrors the Trump Administrations budget proposal that would decrease the a...

latest-news-card-1
Human Drugs

FDA Platform Technology OK for Sarepta Vector

FDA grants platform technology designation to a Sarepta viral vector used in an investigational gene therapy to treat a form of muscular dystrophy.

latest-news-card-1
Human Drugs

New Safety-Related Hernia Mesh Label Recommendations

FDA posts a draft guidance entitled Hernia Mesh Package Labeling Recommendations.

latest-news-card-1
Human Drugs

Drug Labeling Improved for Pregnant Women: FDA

FDA confirms that all drugs now have updated labeling to better provide health risk information to pregnant women.

latest-news-card-1
Human Drugs

4 States Want Mifepristone REMS Ended

California, Massachusetts, New Jersey, and New York ask FDA to cancel the mifepristone REMS program requirements in their states or decline to enforce...

latest-news-card-1
FDA General

Makary Pushes for Reductions in Regulatory Barriers

FDA commissioner Marty Makary promises that the agency will listen to stakeholder ideas on reducing regulatory barriers and evolving its processes by ...